Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

KOSDAQ:A213420
KOSDAQ:A213420Semiconductor

Asian Stocks Trading Below Estimated Value In January 2026

As Asian markets navigate a complex landscape of geopolitical tensions and economic shifts, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In this environment, a good stock is often characterized by strong fundamentals and resilience to external pressures, making it an attractive option for those seeking potential value in the region.
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Is It Too Late To Consider Karooooo (KARO) After Its Strong Share Price Run?

After a strong run, you might be wondering whether Karooooo is still reasonably priced or starting to look stretched at current levels. The stock last closed at US$50.84, with returns of 8.6% over the past week, 7.3% over the last month, 13.8% year to date, and 19.6% over the past year. This puts recent price action front and center for anyone thinking about value. Over the past three years, Karooooo has delivered a total return of 122.8%, which gives useful context to the shorter term moves...
NasdaqGM:ALT
NasdaqGM:ALTBiotechs

Altimmune (ALT) Valuation Check After Pemvidutide’s FDA Breakthrough Therapy Designation

FDA Breakthrough designation puts pemvidutide in focus Altimmune (ALT) has drawn fresh attention after the FDA granted Breakthrough Therapy Designation to its lead candidate pemvidutide for MASH, based on mid stage trial data showing significant disease resolution. See our latest analysis for Altimmune. The FDA Breakthrough Therapy news has arrived during a period of building momentum for Altimmune, with the 7 day share price return of 33.49% and year to date share price return of 61.25%...
XTRA:LXS
XTRA:LXSChemicals

Does LANXESS (XTRA:LXS) Adipic Acid Price Hike Reveal a Shifting Specialty Chemicals Profit Playbook?

Lanxess AG recently announced a price increase for adipic acid within its specialty chemicals portfolio, alongside plans to present at the 25th German Corporate Conference in Frankfurt on 21 January 2026, featuring IR managers Jens Ussler and Thomas Kaiser. This combination of a core product price adjustment and direct investor engagement highlights how Lanxess is actively managing its positioning in key chemical value chains. Next, we’ll examine how Lanxess’s adipic acid price increase...
TSXV:LMN
TSXV:LMNSoftware

Is Lumine Group (TSXV:LMN) Now Attractive After A 36.6% Share Price Slide?

If you are wondering whether Lumine Group is offering good value at its current share price, it helps to first line up what the market has been doing with the stock recently. Lumine Group shares last closed at CA$24.11, after a 1.5% decline over the past week, an 11.8% decline over 30 days and a 36.6% decline over the last year, which has likely changed how some investors think about its risk and potential. Recent coverage has focused on Lumine Group's position as a software player on the...
ADX:HAYAH
ADX:HAYAHInsurance

Middle Eastern Penny Stocks To Consider In January 2026

Most Gulf markets have recently seen declines due to geopolitical and policy uncertainties, with investor sentiment cautious amid fluctuating oil prices and regional tensions. Despite these challenges, the search for growth opportunities continues, particularly in less conventional areas of the market. Penny stocks—often associated with smaller or newer companies—remain a relevant investment area that can offer significant returns when backed by strong financial health and fundamentals.